What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?

Drugs and Aging

Volumn 25, Issue 9, 2008, Pages 717-728

  Bhatt, Nitin Y ^a   Wood, Karen L ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Chronic obstructive pulmonary disease, general

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; FENOTEROL; SALBUTAMOL;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC ACCURACY; ELDERLY CARE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; LUNG FUNCTION; MENTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SMOKING; SPIROMETRY; TACHYCARDIA; URINE RETENTION;

AGED; AGING; BRONCHODILATOR AGENTS; CLINICAL TRIALS AS TOPIC; FORCED EXPIRATORY VOLUME; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; VITAL CAPACITY;

EID: 50249154032     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200825090-00001     Document Type: Review

References (78)

1. Piquette C, Rennard S, Snider G. Chronic bronchitis and emphysema. In: Murray J, Nadel J, editors. Textbook of respiratory medicine. Philadelphia (PA): W.B. Saunders Co., 2000: 1187-245
2. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001 Apr; 163 (5): 1256-76
3. Global strategy for the diagnosis, management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2007 [online]. Available from URL: http://www.goldcopd.org [Accessed 2008 Mar]
4. Celli BR, MacNee W, Committee Members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004 Jun; 23 (6): 932-46
5. Halbert RJ, Isonaka S, George D, et al. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003 May; 123 (5): 1684-92
6. Nacul LC, Soljak M, Meade T. Model for estimating the population prevalence of chronic obstructive pulmonary disease: cross sectional data from the Health Survey for England. Popul Health Metr 2007; 5: 8
7. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance: United States, 1971-2000. MMWR Surveill Summ 2002 Aug 2; 51 (6): 1-16
8. Holguin F, Folch E, Redd SC, et al. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005 Oct; 128 (4): 2005-11
9. National Heart Lung, and Blood Institute. 2007 NHLBI morbidity and mortality chart book. Bethesda (MA): National Institutes of Health, 2007
10. Waterer GW, Wan JY, Kritchevsky SB, et al. Airflow limitation is underrecognized in well-functioning older people. J Am Geriatr Soc 2001 Aug; 49 (8): 1032-8
11. Coultas DB, Mapel D, Gagnon R, et al. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001 Aug 1; 164 (3): 372-7
12. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Respir Care 2000 May; 45 (5): 513-30
13. Sobol BJ. Assessment of ventilatory abnormality in the asymptomatic subject: an exercise in futility. Thorax 1966 Sep; 21 (5): 445-9
14. Sobol BJ, Sobol PG. Per cent of predicted as the limit of normal in pulmonary function testing: a statistically valid approach. Thorax 1979 Feb; 34 (1): 1-3
15. Miller MR, Pincock AC. Predicted values: how should we use them? Thorax 1988 Apr; 43 (4): 265-7
16. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999 Jan 1; 159 (1): 179-87
17. Hnizdo E, Glindmeyer HW, Petsonk EL, et al. Case definitions for chronic obstructive pulmonary disease. COPD 2006 Jun; 3 (2): 95-100
18. American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis 1986 Jun; 133 (6): 1205-9
19. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991 Nov; 144 (5): 1202-18
20. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005 Nov; 26 (5): 948-68
21. Janssens JP. Aging of the respiratory system: impact on pulmonary function tests and adaptation to exertion. Clin Chest Med 2005 Sep; 26 (3): 469-84, vi-vii
22. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999 Jan 1; 13 (1): 197-205
23. Zeleznik J. Normative aging of the respiratory system. Clin Geriatr Med 2003 Feb; 19 (1): 1-18
24. Turner JM, Mead J, Wohl ME. Elasticity of human lungs in relation to age. J Appl Physiol 1968 Dec; 25 (6): 664-71
25. Verbeken EK, Cauberghs M, Mertens I, et al. The senile lung: comparison with normal and emphysematous lungs: 1. Structural aspects. Chest 1992 Mar; 101 (3): 793-9
26. Gillooly M, Lamb D. Airspace size in lungs of lifelong non-smokers: effect of age and sex. Thorax 1993 Jan; 48 (1): 39-43
27. Edge JR, Millard FJ, Reid L, et al. The radiographic appearances of the chest in persons of advanced age. Br J Radiol 1964 Oct; 37: 769-74
28. Estenne M, Yernault JC, De Troyer A. Rib cage and diaphragm-abdomen compliance in humans: effects of age and posture. J Appl Physiol 1985 Dec; 59 (6): 1842-8
29. Enright PL, Kronmal RA, Higgins MW, et al. Prevalence and correlates of respiratory symptoms and disease in the elderly. Cardiovascular Health Study. Chest 1994 Sep; 106 (3): 827-34
30. Enright PL, Kronmal RA, Manolio TA, et al. Respiratory muscle strength in the elderly: correlates and reference values. Cardiovascular Health Study Research Group. Am J Respir Crit Care Med 1994 Feb; 149 (2 Pt 1): 430-8
31. Polkey MI, Harris ML, Hughes PD, et al. The contractile properties of the elderly human diaphragm. Am J Respir Crit Care Med 1997 May; 155 (5): 1560-4
32. Tolep K, Higgins N, Muza S, et al. Comparison of diaphragm strength between healthy adult elderly and young men. Am J Respir Crit Care Med 1995 Aug; 152 (2): 677-82
33. Enright PL, Adams AB, Boyle PJR, et al. Spirometry and maximal respiratory pressure references from healthy Minnesota 65- to 85-year-old women and men. Chest 1995 Sep; 108 (3): 663-9
34. de Bisschop C, Marty ML, Tessier JF, et al. Expiratory flow limitation and obstruction in the elderly. Eur Respir J 2005 Oct 1; 26 (4): 594-601
35. Niewoehner DE, Kleinerman J. Morphologic basis of pulmonary resistance in the human lung and effects of aging. J Appl Physiol 1974 Apr; 36 (4): 412-8
36. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981 Jun; 123 (6): 659-64
37. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983 Jun; 127 (6): 725-34
38. van Pelt W, Borsboom GJ, Rijcken B, et al. Discrepancies between longitudinal and cross-sectional change in ventilatory function in 12 years of follow-up. Am J Respir Crit Care Med 1994 May; 149 (5): 1218-26
39. Cohn JE, Donoso HD. Mechanical properties of lung in normal men over 60 years old. J Clin Invest 1963 Sep; 42: 1406-10
40. Sprung J, Gajic O, Warner DO. Review article: age related alterations in respiratory function - anesthetic considerations. [Article de synthese: Les modifications de fonction respiratoire liees a l'age - considerations anesthesiques]. Can J Anaesth 2006 Dec; 53 (12): 1244-57
41. Zaugg M, Lucchinetti E. Respiratory function in the elderly. Anesthesiol Clin North America 2000 Mar; 18 (1): 47-58, vi
42. Fowler RW, Pluck RA, Hetzel MR. Maximal expiratory flow-volume curves in Londoners aged 60 years and over. Thorax 1987 Mar; 42 (3): 173-82
43. Babb TG, Rodarte JR. Mechanism of reduced maximal expiratory flow with aging. J Appl Physiol 2000 Aug; 89 (2): 505-11
44. DeLorey DS, Babb TG. Progressive mechanical ventilatory constraints with aging. Am J Respir Crit Care Med 1999 Jul; 160 (1): 169-77
45. Bellia V, Cibella F, Cuttitta G, et al. Effect of age upon airway obstruction and reversibility in adult patients with asthma. Chest 1998 Nov; 114 (5): 1336-42
46. Connolly MJ, Crowley JJ, Charan NB, et al. Impaired bronchodilator response to albuterol in healthy elderly men and women. Chest 1995 Aug; 108 (2): 401-6
47. Kradjan WA, Driesner NK, Abuan TH, et al. Effect of age on bronchodilator response. Chest 1992 Jun; 101 (6): 1545-51
48. Barros MJ, Rees PJ. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction. Resp Med 1990 Sep; 84 (5): 371-5
49. van Schayck C, Folgering H, Harbers H, et al. Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis. Thorax 1991; 46 (5): 355-9
50. Schmidt CD, Dickman ML, Gardner RM, et al. Spirometric standards for healthy elderly men and women: 532 subjects, ages 55 through 94 years. Am Rev Respir Dis 1973 Oct; 108 (4): 933-9
51. Milne JS, Williamson J. Respiratory function tests in older people. Clin Sci 1972 Mar; 42 (3): 371-81
52. Enright PL, Kronmal RA, Higgins M, et al. Spirometry reference values for women and men 65 to 85 years of age: Cardiovascular Health Study. Am Rev Respir Dis 1993 Jan; 147 (1): 125-33
53. Medbo A, Melbye H. Lung function testing in the elderly: can we still use FEV1/FVC<70% as a criterion of COPD? Respir Med 2007 Jun; 101 (6): 1097-105
54. Garcia-Rio F, Pino JM, Dorgham A, et al. Spirometric reference equations for European females and males aged 65-85 yrs. Eur Respir J 2004 Sep; 24 (3): 397-405
55. Falaschetti E, Laiho J, Primatesta P, et al. Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J 2004 Mar; 23 (3): 456-63
56. Margolis ML, Montoya FJ, Palma Jr WR. Pulmonary function tests: comparison of 95th percentile-based and conventional criteria of normality. South Med J 1997 Dec; 90 (12): 1187-91
57. Hardie JA, Buist AS, Vollmer WM, et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002 Nov; 20 (5): 1117-22
58. Roberts SD, Farber MO, Knox KS, et al. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006 Jul 1; 130 (1): 200-6
59. Lau AC-W, Ip MS-M, Lai C-W, et al. Variability of the prevalence of undiagnosed airflow obstruction in smokers using different diagnostic criteria. Chest 2008 Jan 1; 133 (1): 42-8
60. Celli BR, Halbert RJ, Isonaka S, et al. Population impact of different definitions of airway obstruction. Eur Respir J 2003 Aug; 22 (2): 268-73
61. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not <70%. Chest 2007 Feb; 131 (2): 349-55
62. Johannessen A, Omenaas ER, Bakke PS, et al. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005 Oct; 60 (10): 842-7
63. Johannessen A, Lehmann S, Omenaas ER, et al. Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006 Jun 15; 173 (12): 1316-25
64. Shirtcliffe P, Weatherall M, Marsh S, et al. COPD prevalence in a random population survey: a matter of definition. Eur Respir J 2007 Aug; 30 (2): 232-9
65. Perez-Padilla R, Torre Bouscoulet L, Vazquez-Garcia JC, et al. Spirometry reference values after inhalation of 200 microg of salbutamol. Arch Bronconeumol 2007 Oct; 43 (10): 530-4
66. Perez-Padilla R, Hallal PC, Vazquez-Garcia JC, et al. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 2007 Jun; 4 (2): 113-20
67. Kim SJ, Suk MH, Choi HM, et al. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea. Int J Tuberc Lung Dis 2006 Dec; 10 (12): 1393-8
68. Mannino DM, Sonia Buist A, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007 Mar; 62 (3): 237-41
69. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994 Nov 16; 272 (19): 1497-505
70. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the Lung Health Study. Am J Respir Crit Care Med 2000 Feb; 161 (2 Pt 1): 381-90
71. Petty TL, Weinmann GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute Workshop summary. Bethesda, Maryland, August 29-31, 1995. JAMA 1997 Jan 15; 277 (3): 246-53
72. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000 Apr; 117 (4): 1146-61
73. Parkes G, Greenhalgh T, Griffin M, et al. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ 2008; 336: 598-600
74. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007 Sep 15; 176 (6): 532-55
75. Qaseem A, Snow V, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2007 Nov; 147 (9): 633-8
76. Wilt TJ, Niewoehner D, Kane RL, et al. Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res 2007 Jan; 9 (1): 21-32
77. Lin K, Watkins B, Johnson T, et al. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2008 Apr 1; 148 (7): 535-43
78. Kunisaki KM, Rice KL, Niewoehner DE. Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: an appraisal of published evidence. Drugs Aging 2007; 24 (4): 303-24